TRDA
Entrada Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
3.77 / 10Overall Score
NeturalInvestment Rating
3.77 / 10Overall Score
NeturalInvestment Rating
Is TRDA a Buy, Sell, or Hold?
- Based on a composite score of 3.77/10, we rate TRDA as a Netural. Our analysis breaks down into 3.44/10 for Fundamentals, 3.94/10 for Technicals, and 3.85/10 for Sentiment, indicating the stock is likely to consolidate sideways.
What is the current technical signals for TRDA?
Is TRDA fundamentally strong?
What is the analyst consensus for TRDA?
Is TRDA a Buy, Sell, or Hold?
- Based on a composite score of 3.77/10, we rate TRDA as a Netural. Our analysis breaks down into 3.44/10 for Fundamentals, 3.94/10 for Technicals, and 3.85/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is TRDA fundamentally strong?
What is the current technical signals for TRDA?
What is the analyst consensus for TRDA?
